August 4, 2014 / 12:47 PM / 3 years ago

BUZZ-Tekmira Pharmaceuticals Corp: Developing Ebola drug

** Canadian drugmaker's U.S.-listed shares up 7.6 pct at $15.36 premarket

** Tekmira hopes to produce first treatment for Ebola virus

** U.S. FDA says willing to work with companies testing Ebola drug; would consider special emergency new drug applications

** Earlier this month, FDA put clinical trial of Tekmira's TKM-Ebola on hold

** Tekmira's shares rose sharply on Friday on news Ebola outbreak in West Africa has intensified

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below